The International Society of Urological Pathology (ISUP) Vancouver classification of renal neoplasia

American Journal of Surgical Pathology

Volumn 37, Issue 10, 2013, Pages 1469-1489

  Srigley, John R ^a   Delahunt, Brett ^b   Eble, John N ^c   Egevad, Lars ^g   Epstein, Jonathan I ^d   Grignon, David ^c   Hes, Ondrej ^h   Moch, Holger ⁱ   Montironi, Rodolfo ^j   Tickoo, Satish K ^d   Zhou, Ming ^e   Argani, Pedram ^f   Abraham, Anila ^k   Adeniran, Adebowale ^k   Ahmed, Khalid ^k   Al Ahmadie, Hikmat ^k   Algaba, Ferran ^k   Allan, Robert ^k   Amin, Mahul ^k   Axcrona, Ulrika ^k   Barry, Marc ^k   Baydar, Dilek ^k   Bégin, Louis ^k   Berney, Dan ^k   Bethwaite, Peter ^k   Billis, Athanase ^k   Birbe, Ruth ^k   Bonsib, Stephen ^k   Bostwick, David ^k   Brimo, Fadi ^k   Cathro, Helen ^k   Chen, Ying Bei ^k   Cheng, Liang ^k   Cheville, John ^k   Cho, Yong Mee ^k   Chuang, Ai Ying ^k   Cohen, Cynthia ^k   Crist, Henry ^k   Delprado, Warick ^k   Deng, Fang Ming ^k   Evans, Andrew ^k   Fadare, Oluwole ^k   Fajardo, Daniel ^k   Falzarano, Sara ^k   Fine, Samson ^k   Fleming, Stewart ^k   Fridman, Eddie ^k   Furusato, Bungo ^k   Ganji, Masoud ^k   Ghayouri, Masoumeh ^k   Giannico, Giovanna ^k   Gokden, Neriman ^k   Griffiths, David ^k   Gupta, Nilesh ^k   Hameed, Omar ^k   Hirsch, Michelle ^k   Huang, Jiaoti ^k   Huang, Wei ^k   Van De Kaa, Christina Hulsbergen ^k   Humphrey, Peter ^k   Hussein, Sundus ^k   Iczkowski, Kenneth ^k   Jimenez, Rafael ^k   Jones, Edward ^k   Jufe, Laura Irene ^k   Kench, James ^k   Kida, Masatoshi ^k   Kristiansen, Glen ^k   Kunju, Lakshmi Priya ^k   Lane, Zhaoli ^k   Latour, Mathieu ^k   Lewin, Claudio ^k   Lie, Kathrine ^k   Lloreta, Josep ^k   Loftus, Barbara ^k   Lopez Beltran, Antonio ^k   Maclean, Fiona ^k   Magi Galluzzi, Cristina ^k   Martignoni, Guido ^k   McHale, Teresa ^k   McKenney, Jesse ^k   Merino, Maria ^k   Miller, Rose ^k   Miyamoto, Hiroshi ^k   Murphy, Hedwig ^k   Nacey, John ^k   Nazeer, Tipu ^k   Nesi, Gabriella ^k   Netto, George ^k   Nichols, Peter ^k   O'Donnell, Marie ^k   Olgac, Semra ^k   Orozco, Roberto ^k   Osunkoya, Adeboye ^k   Ozagari, Aysim ^k   Pan, Chin Chen ^k   Parwani, Anil ^k   Perry Keene, Joanna ^k   Petraki, Constantina ^k   Picken, Maria ^k   Pyda Karwicka, Maria ^k   Reuter, Victor ^k   Rezaei, Katayoon ^k   Rioux Leclercq, Nathalie ^k   Robinson, Brian ^k   Rohan, Stephen ^k   Ronchetti, Ruben ^k   Russell, Laurie ^k   Samaratunga, Hemamali ^k   Scarpelli, Marina ^k   Shabaik, Ahmed ^k   Shah, Rajal ^k   Shanks, Jonathan ^k   Shen, Steven ^k   Shevchuk, Maria ^k   Sibony, Mathilde ^k   Srinivasan, Bhuvana ^k   Susani, Martin ^k   Suzigan, Sueli ^k   Sweet, Joan ^k   Takahashi, Hiroyuki ^k   Tamboli, Pheroze ^k   Tan, Puay Hoon ^k   Trias, Isabel ^k   Trpkov, Kiril ^k   True, Larry ^k   Tsuzuki, Toyonori ^k   Vakar Lopez, Funda ^k   Van Der Kwast, Theo ^k   Wang, Cheng ^k   Warren, Anne ^k   Yao, Jorge ^k   Yilmaz, Asli ^k   Zhao, Jin ^k   Zynger, Debra ^k   more..

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d DEPARTMENT OF PATHOLOGY   (United States)

^e MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^f NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^g KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^h CHARLES UNIVERSITY   (Czech Republic)

ⁱ UNIVERSITY OF ZURICH   (Switzerland)

^j United Hospitals   (Italy)

^k Section of Pathological Anatomy Polytechnic University of Medicine United Hospitals ^*

more..

Author keywords

Classification; Diagnosis; International Society of Urological Pathology; Morphology; Renal cell carcinoma; Renal neoplasia

Indexed keywords

EID: 84900390656     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e318299f2d1     Document Type: Article

References (203)

1. Thoenes W, Sto rkel S, Rumpelt HJ. Histopathology and classification of renal cell tumors (adenomas, oncocytomas and carcinomas). The basic cytological and histopathological elements and their use for diagnostics. Pathol Res Pract. 1986;181:125-143.
2. Kovacs G, Akhtar M, Beckwith BJ, et al. The Heidelberg classification of renal cell tumours. J Pathol. 1997;183:131-133.
3. Sto rkel S, Eble JN, Adlakha K, et al. Classification of renal cell carcinoma:Workgroup N.o.
4. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer. 1997;80:987-989.
5. Eble JN, Sauter G, Epstein JI, et al. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. Lyon, France: IARC; 2004.
6. Srigley JR, Delahunt B. Uncommon and recently described renal carcinomas. Mod Pathol. 2009;22(suppl 2):S2-S23.
7. Delahunt B, Egevad L, Montironi R, et al. International Society of Urological Pathology (ISUP) consensus conference on renal neoplasia: rationale and organization. Am J Surg Pathol. 2013;37:1463-1468.
8. Murphy WM, Beckwith JB, Farrow GM. Atlas of Tumor Pathology Fascicle 11, Tumors of the Kidney, Bladder and Related Urinary Structures. 3rd ed. Washington, DC: Armed Forces Institute of Pathology; 1994.
9. MacLennan GT, Farrow GM, Bostwick DG. Low-grade collecting duct carcinoma of the kidney: report of 13 cases of low-grade mucinous tubolocystic renal carcinoma of possible collecting duct origin. Urology. 1997;50:679-684.
10. Masson P. Tumeurs Humaines Histologie, Diagnostics et Techniques. 2nd ed. Paris: Librairie Maloine; 1956;1214.
11. Azoulay S, Viellefond A, Paraf F, et al. Tubulocystic carcinoma of the kidney: a new entity among renal tumors. Virchows Arch. 2007;451:905-909.
12. Yang XJ, Zhou M, Hes O, et al. Tubulocystic carcinoma of the kidney; clinicopathologic and molecular characterization. Am J Surg Pathol. 2008;32:177-187.
13. Amin MB, MacLennan GT, Gupta R, et al. Tubulocystic carcinoma of the kidney; clinicopathologic analysis of 31 cases of a distinctive rare subtype of renal cell carcinoma. Am J Surg Pathol. 2009;33:384-392.
14. Zhou M, Yang XJ, Lopez JI, et al. Renal Tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification. Am J Surg Pathol. 2009;33:1840-1849.
15. Hora M, U rge T, Eret V, et al. Tubulocystic renal carcinoma: a clinical perspective. World J Urol. 2011;29:349-354.
16. Deshmukh M, Shet T, Bakshi G, et al. Tubulocystic carcinoma of kidney associated with papillary renal cell carcinoma. Indian J Pathol Microbiol. 2011;54:127-130.
17. Al Hussain TO, Cheng L, Zhang S, et al. De-differentiated tubulocystic carcinoma of the kidney: a series of 3 cases with FISH analysis. Hum Pathol. 2013;44:1406-1411.
18. Osunkoya AO, Young AN, Wang W, et al. Comparison of gene expression profiles in tubulocystic carcinoma and collecting duct carcinoma of the kidney. Am J Surg Pathol. 2009;33:1103-1106.
19. Moses KA, DeCaro JJ, Osunkoya AO, et al. Tubulocystic carcinoma of the kidney: a case report of natural history and long-term follow-up. ScientificWorldJournal. 2010;10:586-589.
20. Mego M, Sycova-Mila Z, Rejlekova K, et al. Sunitinib in the treatment of tubulocystic carcinoma of the kidney. A case report. Ann Oncol. 2008;19:1655-1656.
21. Tickoo SK, dePeralta-Venturina MN, Harik LR, et al. Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia. Am J Surg Pathol. 2006;30:141-153.
22. Tickoo SK, Reuter VE. Differential diagnosis of renal tumors with papillary architecture. Adv Anat Pathol. 2011;18:120-132.
23. Enoki Y, Katoh G, Okabe H, et al. Clinicopathological features and CD57 expression in renal cell carcinoma in acquired cystic disease of the kidneys: with special emphasis on a relation to the duration of haemodialysis, the degree of calcium oxalate deposition, histological type, and possible tumorigenesis. Histopathology. 2010;56:384-394.
24. Nouh MA, Kuroda N, Yamashita M, et al. Renal cell carcinoma in patients with end-stage renal disease: relationship between histological type and duration of dialysis. BJU Int. 2010;105:620-627.
25. Sassa N, Hattori R, Tsuzuki T, et al. Renal cell carcinomas in haemodialysis patients: does haemodialysis duration influence pathological cell types and prognosis? Nephrol Dial Transplant. 2011;26:1677-1682.
26. Bhatnagar R, Alexiev BA. Renal-cell carcinomas in end-stage kidneys: a clinicopathological study with emphasis on clear-cell papillary renal-cell carcinoma and acquired cystic kidney diseaseassociated carcinoma. Int J Surg Pathol. 2012;20:19-28.
27. Sule N, Yakupoglu U, Shen SS, et al. Calcium oxalate deposition in renal cell carcinoma associated with acquired cystic kidney disease: a comprehensive study. Am J Surg Pathol. 2005;29: 443-451.
28. Kuroda N, Tamura M, Hamaguchi N, et al. Acquired cystic disease-associated renal cell carcinoma with sarcomatoid change and rhabdoid features. Ann Diagn Pathol. 2011;15:462-466.
29. Pan CC, Chen YJ, Chang LC, et al. Immunohistochemical and molecular genetic profiling of acquired cystic disease-associated renal cell carcinoma. Histopathology. 2009;55:145-153.
30. Kuroda N, Yamashita M, Kakehi Y, et al. Acquired cystic diseaseassociated renal cell carcinoma: an immunohistochemical and fluorescence in situ hybridization study. Med Mol Morphol. 2011;44:228-232.
31. Kuntz E, Yusenko MV, Nagy A, et al. Oligoarray comparative genomic hybridization of renal cell tumors that developed in patients with acquired cystic renal disease. Hum Pathol. 2010;41:1345-1349.
32. Kuroda N, Shiotsu T, Hes O, et al. Acquired cystic diseaseassociated renal cell carcinoma with gain of chromosomes 3, 7, and 16, gain of chromosome X, and loss of chromosome Y. Med Mol Morphol. 2010;43:231-234.
33. Gobbo S, Eble JN, Grignon DJ, et al. Clear cell papillary renal cell carcinoma: a distinct histopathologic and molecular genetic entity. Am J Surg Pathol. 2008;32:1239-1245.
34. Aydin H, Chen L, Cheng L, et al. Clear cell tubulopapillary renal cell carcinoma: a study of 36 distinctive low-grade epithelial tumors of the kidney. Am J Surg Pathol. 2010;34:1608-1621.
35. Michal M, Hes O, Nemcova J, et al. Renal angiomyoadenomatous tumor: morphologic, immunohistochemical, and molecular genetic study of a distinct entity. Virchows Arch. 2009;454:89-99.
36. Mai KT, Kohler DM, Belanger EC, et al. Sporadic clear cell renal cell carcinoma with diffuse cytokeratin 7 immunoreactivity. Pathology. 2008;40:481-486.
37. Adam J, Couturier J, Molinie V, et al. Clear-cell papillary renal cell carcinoma: 24 cases of a distinct low-grade renal tumour and a comparative genomic hybridization array study of seven cases. Histopathology. 2011;58:1064-1071.
38. Rohan SM, Xiao Y, Liang Y, et al. Clear-cell papillary renal cell carcinoma: molecular and immunohistochemical analysis with emphasis on the von Hippel-Lindau gene and hypoxia-inducible factor pathway-related proteins. Mod Pathol. 2011;24:1207-1220.
39. Behdad A, Monzon FA, Hes O, et al. Relationship between sporadic clear cell-papillary renal cell carcinoma (CP-RCC) and renal angiomyoadenomatous tumor (RAT) of the kidney: analysis by virtual-karyotyping, fluorescent in situ analysis and immunohistochemistry (IHC). Mod Pathol. 2011;24(S1):179A.
40. Kuroda N, Hosokawa T, Michal M, et al. Clear cell renal cell carcinoma with focal renal angiomyoadenomatous tumorlike area. Ann Diagn Pathol. 2011;15:202-206.
41. Wolfe A, Dobin SM, Grossmann P, et al. Clonal trisomies 7,10 and 12, normal 3p and absence of VHL gene mutation in a clear cell tubulopapillary carcinoma of the kidney. Virchows Arch. 2011;459: 457-463.
42. Argani P, Antonescu CR, Couturier J, et al. PRCC-TFE3 renal carcinomas: Morphologic, immunohistochemical, ultrastructural, and molecular analysis of an entity associated with the t(X;1)(p11.2;q21). Am J Surg Pathol. 2002;26:1553-1566.
43. Argani P, Antonescu CR, Illei PB, et al. Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents. Am J Pathol. 2001;159:179-192.
44. Ladanyi M, Lui MY, Antonescu CR, et al. The der(17)t(X;17) (p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25. Oncogene. 2001;20:48-57.
45. Clark J, Lu YJ, Sidhar SK, et al. Fusion of splicing factor genes PSF and NonO (p54nrb) to the TFE3 gene in papillary renal cell carcinoma. Oncogene. 1997;15:2233-2239.
46. Argani P, Lui MY, Couturier J, et al. A novel CLTC-TFE3 gene fusion in pediatric renal adenocarcinoma with t(X;17)(p11.2;q23). Oncogene. 2003;22:5374-5378.
47. Argani P, Olgac S, Tickoo SK, et al. Xp11 translocation renal cell carcinoma in adults: expanded clinical, pathologic, and genetic spectrum. Am J Surg Pathol. 2007;31:1149-1160.
48. Komai Y, Fujiwara M, Fujii Y, et al. Adult Xp11 translocation renal cell carcinoma diagnosed by cytogenetics and immunohistochemistry. Clin Cancer Res. 2009;15:1170-1176.
49. Zhong M, De Angelo P, Osborne L, et al. Dual-color, break-apart FISH assay on paraffin-embedded tissues as an adjunct to diagnosis of Xp11 translocation renal cell carcinoma and alveolar soft part sarcoma. Am J Surg Pathol. 2010;34:757-766.
50. Argani P, Lae M, Ballard ET, et al. Translocation carcinomas of the kidney after chemotherapy in childhood. J Clin Oncol. 2006;24:1529-1534.
51. Argani P, Hicks J, DeMarzo A, et al. Xp11 translocation renal cell carcinoma (RCC): extended immunohistochemical (IHC) profile emphasizing novel RCC markers. Am J Surg Pathol. 2010;34: 1295-1303.
52. Argani P, Lal P, Hutchinson B, et al. Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: A sensitive and specific immunohistochemical assay. Am J Surg Pathol. 2003;27:750-761.
53. Macher-Geoppinger S, Roth W, Wagener N, et al. Molecular heterogeneity of TFE3 activation in renal cell carcinomas. Mod Pathol. 2012;25:308-315.
54. Green WM, Yonescu R, Morsberger L, et al. Utilization of a TFE3 break apart FISH assay in a renal tumor consultation service. Am J Surg Pathol. 2013;37:1150-1163.
55. Mosquera JM, Dal Cin P, Mertz KD, et al. Validation of a TFE3 break-apart FISH assay for Xp11.2 translocation renal cell carcinoma. Diagn Mol Pathol. 2011;20:129-137.
56. Martignoni G, Pea M, Gobbo S, et al. Cathepsin-K immunoreactivity distinguishes MiTF/TFE family renal translocation carcinomas from other renal carcinomas. Mod Pathol. 2009;22: 1016-1022.
57. Martignoni G, Gobbo S, Camparo P, et al. Differential expression of cathepsin-K in neoplasms harbouring TFE3 gene fusions. Mod Pathol. 2011;24:1313-1319.
58. Geller JI, Argani P, Adeniran A, et al. Translocation renal cell carcinoma: lack of negative impact due to lymph node spread. Cancer. 2008;112:1607-1616.
59. Meyer PN, Clark JI, Flanigan RC, et al. Xp11.2 translocation renal cell carcinoma with very aggressive course in five adults. Am J Clin Pathol. 2007;128:70-79.
60. Argani P, Aulmann S, Karanjawala Z, et al. Melanotic Xp11 translocation renal cancers: a distinctive neoplasm with overlapping features of PEComa, carcinoma, and melanoma. Am J Surg Pathol. 2009;33:609-619.
61. Chang IW, Huang HY, Sung MT. Melanotic Xp11 translocation renal cancer: a case with PSF-TFE3 gene fusion and up-regulation of melanogenetic transcripts. Am J Surg Pathol. 2009;33:1894-1901.
62. Argani P, Illei P, Netto G, et al. A distinctive subset of PEComas harbor TFE3 gene fusions. Am J Surg Pathol. 2010;34:1395-1406.
63. Tanaka M, Kato K, Gomi K, et al. Perivascular epithelioid cell tumor with SFPQ/PSF-TFE3 gene fusion in a patient with advanced neuroblastoma. Am J Surg Pathol. 2009;33:1416-1420.
64. Ohe C, Kuroda N, Hes O, et al. A renal epithelioid angiomyolipoma/ perivascular cell tumor with TFE3 gene break visualized by FISH. Med Mol Morphol. 2012;45:234-237.
65. Argani P, Hawkins A, Griffin CA, et al. A distinctive pediatric renal neoplasm characterized by epithelioid morphology, basement membrane production, focal HMB45 immunoreactivity, and t(6;11)(p21.1;q12) chromosome translocation. Am J Pathol. 2001;158:2089-2096.
66. Argani P, Lae M, Hutchinson B, et al. Renal carcinomas with the t(6;11)(p21;q12). Clinicopathologic features and demonstration of the specific Alpha-TFEB gene fusion by immunohistochemistry, RT-PCR, and DNA-PCR. Am J Surg Pathol. 2005;29:230-240.
67. Argani P, Yonescu R, Morsberger L, et al. Molecular confirmation of the t(6;11)(p21;q12) renal cell carcinomas in archival paraffinembedded material using a break-apart TFEB FISH assay expands its clinicopathologic spectrum. Am J Surg Pathol. 2012;36: 1516-1526.
68. Camparo P, Vasiliu V, Molinie V, et al. Renal translocation carcinomas: clinicopathologic, immunohistochemical, and gene expression profiling analysis of 31 cases with a review of the literature. Am J Surg Pathol. 2008;32:656-670.
69. Davis IJ, Hsi BL, Arroyo JD, et al. Cloning of an Alpha-TFEB fusion in renal tumors harboring the t(6;11)(p21;q13) chromosome translocation. Proc Natl Acad Sci USA. 2003;100:6051-6056.
70. Inamura K, Fujiwara M, Togashi Y, et al. Diverse fusion patterns and heterogeneous clinicopathologic features of renal cell carcinoma with t(6;11) translocation. Am J Surg Pathol. 2012;36:35-42.
71. Kuiper RP, Schepens M, Thijssen J, et al. Upregulation of the transcription factor TFEB in t(6;11)(p21;q13)-positive renal cell carcinomas due to promoter substitution. Hum Mol Genet. 2003;12:1661-1669.
72. Pecciarini L, Cangi MG, Lo Cunsolo C, et al. Characterization of t(6;11)(p21;q12) in a renal-cell carcinoma of an adult patient. Genes Chromosomes Cancer. 2007;46:419-426.
73. Zhan HQ, Wang CF, Zhu XZ, et al. Renal cell carcinoma with t(6;11) translocation: a patient case with a novel Alpha-TFEB fusion point. J Clin Oncol. 2010;28:e709-e713.
74. Smith N, Illei P, Gonzalez N, et al. t(6;11) renal cell carcinoma (RCC): report of six new genetically-confirmed cases and expanded Immunohistochemical (IHC) profile. Mod Pathol. 2013;26(S2):250A.
75. Kiuru M, Launonen V, Hietal M, et al. Familial cutaneous leiomyomas associated with renal cell cancer of characteristic histopathology. Am J Pathol. 2001;159:825-829.
76. Kiuru M, Lehtonen R, Arola J, et al. Few FH mutations in sporadic counterparts of tumor types observed in hereditary leiomyomatosis and renal cell cancer families. Cancer Res. 2002;62:4554-4557.
77. Launonen V, Vierimaa O, Kiuru M, et al. Inherited susceptibility to uterine leiomyomas and renal cell cancer. Proc Natl Acad Sci USA. 2002;98:3387-3392.
78. Tomlinson IP, Alam NA, Rowan AJ, et al. Germline mutations in FH predispose to dominantly inherited uterine fibroids, skim leiomyomata and papillary renal cell cancer. Nat Genet. 2002;30:406-410.
79. Alam NA, Rowan AJ, Wortham NC, et al. Genetic and functional analyses of FH mutations in multiple cutaneous and uterine leiomyomatosis, hereditary leiomyomatosis and renal cancer, and fumarate hydratase deficiency. Hum Mol Genet. 2003;12: 1241-1252.
80. Toro JR, Nickerson ML, Wei MH, et al. Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North American. Am J Hum Genet. 2003;73:95-106.
81. Grubb RL, Franks ME, Toro J, et al. Hereditary leiomyomatosis and renal cell cancer: a syndrome associated with an aggressive form of inherited renal cancer. J Urol. 2007;177:2074-2079.
82. Merino MJ, Torres-Cabala C, Pinto P, et al. The morphologic spectrum of kidney tumors in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome. Am J Surg Pathol. 2007;31: 1578-1585.
83. Jung SJ, Chung JI, Park SH, et al. Thyroid follicular carcinomalike tumor of kidney. Am J Surg Pathol. 2006;30:411-415.
84. Amin MB, Gupta R, Ondrej HO, et al. Primary thyroid-like follicular carcinoma of the kidney: report of 6 cases of a histologically distinctive adult renal epithelial neoplasm. Am J Surg Pathol. 2009;33:393-400.
85. Dhillon J, Tannir NM, Matin SF, et al. Thyroid-like follicular carcinoma of the kidney with metastases to the lungs and retroperitoneal lymph nodes. Hum Pathol. 2011;42:146-150.
86. Khoja HA, Almutawa A, Binmahfooz A, et al. Papillary thyroid carcinoma-like tumor of the kidney: a case report. Int J Surg Pathol. 2012;20:411-415.
87. Alessandrini L, Fassan M, Gardiman MP, et al. Thyroid-like follicular carcinoma of the kidney: report of two cases with detailed immunohistochemical profile and literature review. Virchows Arch. 2012;461:345-350.
88. Dhillon J, Mohanty SK, Krishnamurthy S. Cytologic diagnosis of thyroid-like follicular carcinoma of the kidney: a case report. Diagn Cytopathol. 2012. DOI: 10.1002/dc.22930. [Epub ahead of print].
89. Angell SK, Fruthi R, Freiha FS. Primary thyroid-like carcinoma of the kidney. Urology. 1996;48:632-635.
90. William S, Irmgard V, Michael G, et al. Thyroid follicular carcinoma-like renal tumor: a case report with morphologic, immunophenotypic, cytogenetic and scintigraphic studies. Virchows Arch. 2008;452:91-95.
91. Gill AJ, Pachter NS, Chou A, et al. Renal tumors associated with germline SDHB mutation show distinctive morphology. Am J Surg Pathol. 2011;35:1578-1585.
92. Henderson A, Douglas F, Perros P, et al. SDHB-associated renal oncocytoma suggests a broadening of the renal phenotype in hereditary paragangliomatosis. Fam Cancer. 2009;8: 257-260.
93. Housley SL, Lindsay RS, Young B, et al. Renal carcinoma with giant mitochondria associated with germ-line mutation and somatic loss of the succinate dehydrogenase B gene. Histopathology. 2010;56:401-410.
94. Van Nederven FH, Gaal J, Favier J, et al. An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis. Lancet Oncol. 2009;10:764-771.
95. Barletta JA, Hornick JL. Succinate dehydrogenase-deficient tumors: diagnostic advances and clinical implications. Adv Anat Pathol. 2012;19:193-203.
96. Gill AJ. Succinate dehydrogenase (SDH) and mitochondrial driven neoplasia. Pathology. 2012;44:285-292.
97. Debelenko LV, Raimondi SC, Daw N, et al. Renal cell carcinoma with novel VCL-ALK fusion: new representative of ALKassociated tumor spectrum. Mod Pathol. 2011;24:430-442.
98. Marino-En r?quez A, Ou WB, Weldon CB, et al. ALK rearrangement in sickle cell trait-associated renal medullary carcinoma. Genes Chromosomes Cancer. 2011;50:146-153.
99. Sugawara E, Togashi Y, Kuroda N, et al. Identification of anaplastic lymphoma kinase fusions in renal cancer. Cancer. 2012;118:4427-4436.
100. Sukov WR, Hodge JC, Lohse CM, et al. ALK alterations in adult renal cell carcinoma: frequency, cliniciopathologic features and outcome in a large series of consecutively treated patients. Mod Pathol. 2012;25:1516-1525.
101. Moch H. Cystic renal tumors: new entities and novel concepts. Adv Anat Pathol. 2010;17:209-214.
102. You D, Shim M, Jeong IG, et al. Multilocular cystic renal cell carcinoma: clinicopathological features and preoperative prediction using multiphase computed tomography. BJU Int. 2011;108: 1444-1449.
103. von Teichman A, Comperat E, Behnke S, et al. VHL mutations and dysregulation of pVHL-and PTEN-controlled pathways in multilocular cystic renal cell carcinoma. Mod Pathol. 2011;24: 571-578.
104. Halat S, Eble JN, Grignon DJ, et al. Multilocular cystic renal cell carcinoma is a subtype of clear cell renal cell carcinoma. Mod Pathol. 2010;23:931-936.
105. Williason SR, Halat S, Eble JN, et al. Multilocular cystic renal cell carcinoma. Similarities and differences in immunoprolife compared with clear cell renal cell carcinoma. Am J Surg Pathol. 2012;36: 1425-1433.
106. Suzigan S, Lo pez-Beltran A,Montironi R, et al. Multilocular cystic renal cell carcinoma: a report of 45 cases of a kidney tumor of low malignant potential. Am J Clin Pathol. 2006;125:217-222.
107. Algaba F, Akaza H, Lo pez-Beltran A, et al. Current pathology keys of renal cell carcinoma. Eur Urol. 2011;60:634-643.
108. Stamatiou KN, Sofras F. Multilocular cystic nephroma and multicystic clear cell carcinoma: two faces of the Roman god Janus? Int J Surg Pathol. 2009;17:170-171.
109. Chen YB, Tickoo SK. Spectrum of preneoplastic and neoplastic cystic lesions of the kidney. Arch Pathol Lab Med. 2012;136: 400-409.
110. Suzigan S, Drut R, Faria P, et al. Xp11 translocation carcinoma of the kidney presenting with multilocular cystic renal cell carcinomalike features. Int J Surg Pathol. 2007;15:199-203.
111. Delahunt B, Thornton A. Renal cell carcinoma: a historical perspective. J Urol Pathol. 1996;4:31-49.
112. Mancilla-Jimenez R, Stanley RJ, Blath RA. Papillary renal cell carcinoma: a clinical radiologic and pathologic study of 34 cases. Cancer. 1976;38:2469-2480.
113. Mydlo JH, Bard RH. Analysis of papillary renal adenocarcinoma. Urology. 1987;30:529-534.
114. Kovacs G. Papillary renal cell carcinoma. A morphological and cytogenetic study of 11 cases. Am J Pathol. 1989;134:27-34.
115. Hora M, Hes O, Klecka J, et al. Rupture of papillary renal cell carcinoma. Scand J Urol Nephrol. 2004;38:481-484.
116. Cheville JC, Lohse CM, Zincke BS, et al. Comparison of outcome and prognostic feature among histological subtypes of renal cell carcinoma. Am J Surg Pathol. 2003;27:612-624.
117. Velickovic M, Delahunt B, Sto rkel S, et al. VHL and FHIT locus loss of heterozygosity is common in all renal cancers morphotypes but differs in pattern and prognostic significance. Cancer Res. 2001;61:4815-4819.
118. Morrissey C, Martinez A, Zatyka M, et al. Epigenetic inactivation of RASSFIA 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma. Cancer Res. 2001;61: 7277-7281.
119. Hughson MD, Dickman K, Bigler SA, et al. Clear-cell and papillary carcinoma of the kidney: an analysis of chromosome 3, 7, and 17 abnormalities by microsatellite amplification, cytogenetics, and fluorescence in situ hybridization. Cancer Genet Cytogenet. 1998;106:93-104.
120. Delahunt B, Eble JN. Papillary renal cell carcinoma: a histological and immunohistochemical study of 105 cases. Mod Pathol. 1997;10:537-544.
121. Delahunt B, Eble JN, McCredie M, et al. Morphologic typing of papillary renal cell carcinoma: comparison of growth kinetics and patient survival in 66 cases. Hum Pathol. 2001;32:590-595.
122. Leroy X, Zini L, Leteurtre E, et al. Morphologic subtyping of papillary renal cell carcinoma: correlation with prognosis and different expression of MUC1 between the two subtypes. Mod Pathol. 2002;15:1126-1131.
123. Kim MK, Kim S. Immunohistochemical profile of common epithelial neoplasms arising in the kidney. Appl Immunohistochem Mol Morphol. 2002;10:332-338.
124. Lagner C, Wegscheider BJ, Ratschek M, et al. Keratin immunohistochemistry in renal cell carcinoma subtypes and renal oncocytomas: a systematic analysis of 233 tumors. Virchows Arch. 2004;444:127-134.
125. Zhou M, Roma A, Magi-Galluzzi C. The usefulness of immunohistochemical markers in the differential diagnosis of renal neoplasms. Clin Lab Med. 2005;25:247-257.
126. Jiang F, Richter J, Schraml P, et al. Chromosomal imbalances in papillary renal cell carcinoma: genetic differences between histological subtypes. Am J Pathol. 1998;153:1467-1473.
127. Sanders ME, Mick R, Tomaszewski JE, et al. Unique patterns of allelic imbalance distinguish type 1 from type 2 sporadic papillary renal cell carcinoma. Am J Surg Pathol. 2002;161:997-1005.
128. Furge FA, Chen J, Koeman J, et al. Detection of DNA copy number changes and oncogenic signaling abnormalities from gene expression data reveals MYC activation in high grade papillary renal cell carcinoma. Cancer Res. 2007;67:3171-3176.
129. Antonelli A, Tardanico R, Balzarim P, et al. Cytogenetic features, clinical significance and prognostic impact of type 1 and type 2 papillary renal cell carcinoma. Cancer Genet Cytogenet. 2010;199: 128-133.
130. Yang XJ, Tan M-H, Kim HL, et al. A molecular classification of papillary renal cell carcinoma. Cancer Res. 2005;65:5628-5637.
131. Delahunt B, Cheville JC, Martignoni G, et al. The International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma and other prognostic parameters. Am J Surg Pathol. 2013;37:e33-e47.
132. Adley BP, Smith ND, Nayar R, et al. Birt-Hogg-Dube syndrome: clinicopathologic findings and genetic alterations. Arch Pathol Lab Med. 2006;130:1865-1870.
133. Delongchamps NB, Galmiche L, Eiss D, et al. Hybrid tumour 'oncocytoma-chromophobe renal cell carcinoma' of the kidney: a report of seven sporadic cases. BJU Int. 2009;103:1381-1384.
134. Gobbo S, Eble JN, Delahunt B, et al. Sporadic hybrid oncocytic/ chromophobe tumor of the kidney: a clinicopathologic, histomorphologic, immunohistochemical, ultrastructural, and molecular cytogenetic study of 14 cases. Renal cell neoplasms of oncocytosis have distinct morphologic, immunohistochemical, and cytogenetic profile. Am J Surg Pathol. 2010;34:620-626.
135. Mai KT, Dhamanaskar P, Belanger E, et al. Hybrid chromophobe renal cell neoplasm. Pathol Res Pract. 2005;201:385-389.
136. Pavlovich CP, Walther MM, Eyler RA, et al. Renal tumors in the Birt-Hogg-Dube syndrome. Am J Surg Pathol. 2002;26:1542-1552.
137. Petersson F, Gatalica Z, Grossmann P, et al. Sporadic hybrid oncocytic/chromophobe tumor of the kidney: a clinicopathologic, histomorphologic, immunohistochemical, ultrastructural, and molecular cytogenetic study of 14 cases. Virchows Arch. 2010;456: 355-365.
138. Tickoo SK, Reuter VE, Amin MB, et al. Renal oncocytosis: a morphologic study of fourteen cases. Am J Surg Pathol. 1999;23: 1094-1101.
139. Waldert M, Klatte T, Haitel A, et al. Hybrid renal cell carcinomas containing histopathologic features of chromophobe renal cell carcinomas and oncocytomas have excellent oncologic outcomes. Eur Urol. 2010;57:661-665.
140. Warfel KA, Eble JN. Renal oncocytomatosis. J Urol. 1982;127: 1179-1180.
141. Al-Saleem T, Cairns P, Dulaimi EA, et al. The genetics of renal oncocytosis: a possible model for neoplastic progression. Cancer Genet Cytogenet. 2003;152:23-28.
142. Cossu-Rocca P, Eble JN, Zhang S, et al. Interphase cytogenetic analysis with centromeric probes for chromosomes 1, 2, 6, 10, and 17 in 11 tumors from a patient with bilateral renal oncocytosis. Mod Pathol. 2008;21:498-504.
143. Chen TS, McNally M, Hulbert W, et al. Renal oncocytosis presenting in childhood: a case report. Int J Surg Pathol. 2003;11:325-329.
144. Klomp JA, Petillo D, Niemi NM, et al. Birt-Hogg-Dube renal tumors are genetically distinct from other renal neoplasias and are associated with up-regulation of mitochondrial gene expression. BMC Med Genomics. 2010;3:59.
145. Murakami T, Sano F, Huang Y, et al. Identification and characterization of Birt-Hogg-Dube associated renal carcinoma. J Pathol. 2007;211:524-531.
146. Amin MD, Varma MD, Tickoo SK, et al. Collecting duct carcinoma of the kidney. Adv Anat Pathol. 1997;4:85-94.
147. Srigley JR, Eble JN. Collecting duct carcinoma of the kidney. Semin Diagn Pathol. 1998;15:54-67.
148. Albadine R, Schultz L, Illei P, et al. PAX8 (+)/p63 (-) immunostaining pattern in renal collecting duct carcinoma (CDC): a useful immunoprofile in the differential diagnosis of CDC versus urothelial carcinoma of upper urinary tract. Am J Surg Pathol. 2010;34:969-969.
149. Elwood H, Chaux A, Schultz L, et al. Immunohistochemical analysis of SMARCB1/INI-1 expression in collecting duct carcinoma. Urology. 2011;78:474.e1-474.e5.
150. Pepek JM, Johnstone PA, Jani AB. Influence of demographic factors on outcome of collecting duct carcinoma: a Surveillance, Epidemiology, and End Results (SEER) database analysis. Clin Genitourin Cancer. 2009;7:E24-E27.
151. Peyromaure M, Thiounn N, Scotte F, et al. Collecting duct carcinoma of the kidney: a clinicopathological study of 9 cases. J Urol. 2003;170:1138-1140.
152. Davis CJ Jr,Mostofi FK, Sesterhenn IA. Renal medullary carcinoma. The seventh sickle cell nephropathy. Am J Surg Pathol. 1995;19:1-11.
153. Cheng JX, Tretiakova M, Gong C, et al. Renal medullary carcinoma: rhabdoid features and the absence of INI1 expression as markers of aggressive behavior. Mod Pathol. 2008;21:647-652.
154. Gupta R, Billis A, Shah R, et al. Carcinoma of the collecting ducts of Bellini and renal medullary carcinoma. Am J Surg Pathol. 2012;36:1265-1278.
155. Albadine R, Wang W, Brownlee NA, et al. Topoisomerase II alpha status in renal medullary carcinoma: immuno-expression and gene copy alterations of a potential target of therapy. J Urol. 2009;182:735-740.
156. Schaeffer EM, Guzzo TJ, Furge KA, et al. Renal medullary carcinoma: molecular, pathological and clinical evidence for treatment with topoisomerase-inhibiting therapy. BJU Int. 2010;106:62-65.
157. Gatalica Z, Lilleberg SL, Monzon FA, et al. Renal medullary carcinomas: histopathologic phenotype associated with diverse genotypes. Hum Pathol. 2011;42:1979-1988.
158. Walsh A, Kelly DR, Vaid YN, et al. Complete response to carboplatin, gemcitabine, and paclitaxel in a patient with advanced metastatic renal medullary carcinoma. Pediatr Blood Cancer. 2010;55:1217-1220.
159. Srigley JR, Eble JN, Grignon DJ, et al. Unusual renal cell carcinoma (RCC) with prominent spindle cell change possibly related to the loop of Henle. Mod Pathol. 1999;12:107.
160. Parwani AV, Husain AN, Epstein JI, et al. Low-grade myxoid renal epithelial neoplasms with distal nephron differential. Hum Pathol. 2001;32:506-512.
161. Rakozy C, Schmahl GE, Bagner S, et al. Low-grade tubularmucinous renal neoplasms: morphologic, immunohistochemical, and genetic features. Mod Pathol. 2002;15:1162-1171.
162. Hes I, Hora M, Perez-Montiel DM, et al. Spindle and cuboidal renal cell carcinoma, a tumour having frequent association with nephrolithiasis: report on 11 cases including a case with hybrid conventional renal cell carcinoma/spindle and cuboidal renal cell carcinoma components. Histopathology. 2002;41:549-555.
163. Paner GP, Srigley JR, Radhakrishnan A, et al. Immunohistochemical analysis of mucinous tubular and spindle cell carcinoma and papillary renal cell carcinoma of the kidney. Am J Surg Pathol. 2006;30:13-19.
164. Fine SW, Argani P, DeMarzo AM, et al. Expanding the histologic spectrum of mucinous tubular and spindle cell carcinoma of the kidney. Am J Surg Pathol. 2006;30:1554-1560.
165. Farghaly H. Mucin poor mucinous tubular and spindle cell carcinoma of the kidney, with nonclassic morphologic variant of spindle cell predominance and psammomatous calcification. Ann Diagn Pathol. 2012;16:59-62.
166. Shen SS, Ro JY, Tamboli P, et al. Mucinous tubular and spindle cell carcinoma of kidney is probably a variant of papillary renal cell carcinoma with spindle cell features. Ann Diagn Pathol. 2007;11: 13-21.
167. Cossu-Rocca P, Eble JN, Delahunt B, et al. Renal mucinous tubular and spindle carcinoma lacks the gains of chromosomes 7 and 17 and losses of chromosome Y that are prevalent in papillary renal cell carcinoma. Mod Pathol. 2006;19:488-493.
168. Kuroda N, Naroda T, Tamura M, et al. High-grade mucinous tubular and spindle cell carcinoma: comparative genomic hybridization study. Ann Diagn Pathol. 2011;15:472-475.
169. Ursani NA, Robertson R, Schieman SM, et al. Mucinous tubular and spindle cell carcinoma of kidney without sarcomatoid change showing metastases to liver and retroperitoneal lymph node. Hum Pathol. 2011;42:444-448.
170. Pillay N, Ramdial PK, Cooper K, et al. Mucinous tubular and spindle cell carcinoma with aggressive histomorphology - a sarcomatoid variant. Hum Pathol. 2008;39:966-969.
171. Simon RA, di Sant'agnese PA, Palaputtu GS, et al. Mucinous tubular and spindle cell carcinoma of the kidney with sarcomatoid differentiation. Int J Clin Exp Pathol. 2008;1:180-184.
172. Dhillon J, Amin MB, Selbs E, et al. Mucinous tubular and spindle cell carcinoma of the kidney with sarcomatoid change. Am J Surg Pathol. 2009;33:44-49.
173. Bulimbasic S, Sima R, Kuroda N. Aggressive high-grade mucinous tubular and spindle cell carcinoma. Hum Pathol. 2009;906-907.
174. Larkin J, Fisher R, Pickering L, et al. Metastatic mucinous tubular and spindle cell carcinoma of the kidney responding to Sunitinib. J Clin Oncol. 2010;28:539-539.
175. Martignoni G, Bonetti F, Chilosi M, et al. Cathepsin K expression in the spectrum of perivascular epithelioid cell (PEC) lesions of the kidney. Mod Pathol. 2012;25:100-111.
176. Dickson BC, Brooks JS, Pasha TL, et al. TFE3 expression in tumors of the microphthalmia-associated transcription factor (MiTF) family. Int J Surg Pathol. 2011;19:26-30.
177. Nese N, Martignoni G, Fletcher CD, et al. Pure epithelioid PEComas (so-called epithelioid angiomyolipoma) of the kidney: a clinicopathologic study of 41 cases: detailed assessment of morphology and risk stratification. Am J Surg Pathol. 2011;35: 161-176.
178. Brimo F, Robinson B, Guo C, et al. Renal epithelioid angiomyolipoma with atypia: a series of 40 cases with emphasis on clinicopathologic prognostic indicators of malignancy. Am J Surg Pathol. 2010;34:715-722.
179. He W, Cheville JC, Sadow PM, et al. Pathologic characteristics and clinical outcome of renal epithelioid angiomyolipoma: a multiinstitutional experience based on primary tumor resections. Mod Pathol. 2011;24(S1):196A-197A.
180. Cho NH, Shim HS, Choi YD, et al. Estrogen receptor is significantly associated with the epithelioid variants of renal angiomyolipoma: a clinicopathological and immunohistochemical study of 67 cases. Pathol Int. 2004;54:510-515.
181. Martignoni G, Pea M, Bonetti F, et al. Oncocytoma-like angiomyolipoma. A clinicopathologic and immunohistochemical study of 2 cases. Arch Pathol Lab Med. 2002;126:610-612.
182. Chandrasoma S, Daneshmand S, Wilson S, et al. Renal angiomyolipoma with liposarcomatous transformation: a case report and review of the literature. Urol Oncol. 2004;22:425-427.
183. Nikaido T, Nakano M, Kato M, et al. Characterization of smooth muscle components in renal angiomyolipomas: histological and immunohistochemical comparison with renal capsular leiomyomas. Pathol Int. 2004;54:1-9.
184. Kilicaslan I, Gulluoglu MG, Dogan O, et al. Intraglomerular microlesions in renal angiomyolipoma. Hum Pathol. 2000;31: 1325-1328.
185. Fine SW, Reuter VE, Epstein JI, et al. Angiomyolipoma with epithelial cysts (AMLEC): a distinct cystic variant of angiomyolipoma. Am J Surg Pathol. 2006;30:593-599.
186. Buritica C, Serrano M, Zuluaga A, et al. Mixed epithelial and stromal tumour of the kidney with luteinised ovarian stroma. J Clin Pathol. 2007;60:98-100.
187. Michal M, Hes O, Bisceglia M, et al. Mixed epithelial and stromal tumors of the kidney. A report of 22 cases. Virchows Arch. 2004;445:359-367.
188. Adsay NV, Eble JN, Srigley JR, et al. Mixed epithelial and stromal tumor of the kidney. Am J Surg Pathol. 2000;24:958-970.
189. Yang Y, Ondrej H, Zhang L, et al. Mixed epithelial and stromal tumor of the kidney with cervical and intestinal differentiation. Virchows Arch. 2005;447:669-671.
190. Michal M, Syrucek M. Benign mixed epithelial and stromal tumor of the kidney. Pathol Res Pract. 1998;194:445-448.
191. Pawade J, Soosay GN, Delprado W, et al. Cystic hamartoma of the renal pelvis. Am J Surg Pathol. 1993;17:1169-1175.
192. Beiko DT, Nickel JC, Boag AH, et al. Benign mixed epithelial stromal tumor of the kidney of possible mullerian origin. J Urol. 2001;166:1381-1382.
193. Karafin M, Parwani AV, Netto GJ, et al. Diffuse expression of PAX2 and PAX8 in the cystic epithelium of mixed epithelial stromal tumor, angiomyolipoma with epithelial cysts, and primary renal synovial sarcoma: evidence supporting renal tubular differentiation. Am J Surg Pathol. 2011;35:1264-1273.
194. Kum JB, Grignon DJ, Wang M, et al. Mixed epithelial and stromal tumors of the kidney: evidence for a single cell of origin with capacity for epithelial and stromal differentiation. Am J Surg Pathol. 2011;35:1114-1122.
195. Sukov WR, Cheville JC, Lager DJ, et al. Malignant mixed epithelial and stromal tumor of the kidney with rhabdoid features: report of a case including immunohistochemical, molecular genetic studies and comparison to morphologically similar renal tumors. Hum Pathol. 2007;38:1432-1437.
196. Svec A, Hes O, Michal M, et al. Malignant mixed epithelial and stromal tumor of the kidney. Virchows Arch. 2001;439: 700-702.
197. Antic T, Perry KT, Harrison K, et al. Mixed epithelial and stromal tumor of the kidney and cystic nephroma share overlapping features: reappraisal of 15 lesions. Arch Pathol Lab Med. 2006;130:80-85.
198. Jevremovic D, Lager DJ, Lewin M. Cystic nephroma (multilocular cyst) and mixed epithelial and stromal tumor of the kidney: a spectrum of the same entity? Ann Diagn Pathol. 2006;10: 77-82.
199. Turbiner J, Amin MB, Humphrey PA, et al. Cystic nephroma and mixed epithelial and stromal tumor of kidney: a detailed clinicopathologic analysis of 34 cases and proposal for renal epithelial and stromal tumor (REST) as a unifying term. Am J Surg Pathol. 2007;31:489-500.
200. Zhou M, Kort E, Hoekstra P, et al. Adult cystic nephroma and mixed epithelial and stromal tumor of the kidney are the same disease entity: molecular and histologic evidence. Am J Surg Pathol. 2009;33:72-80.
201. Lane BR, Campbell SC, Remer EM, et al. Adult cystic nephroma and mixed epithelial and stromal tumor of the kidney: clinical, radiographic, and pathologic characteristics. Urology. 2008;71: 1142-1148.
202. Montironi R, Mazzucchelli R, Lopez-Beltran A, et al. Cystic nephroma and mixed epithelial and stromal tumour of the kidney: opposite ends of the spectrum of the same entity? Eur Urol. 2008;54:1237-1246.
203. Argani P, Faria PA, Epstein JI, et al. Primary renal synovial sarcoma: molecular and morphologic delineation of an entity previously included among embryonal sarcomas of the kidney . Am J Surg Pathol. 2000;24:1087-1096.